Cargando…

Cardiovascular risk profile in patients with myelopathy associated with HTLV-1()

HAM/TSP (HTLV-1-associated myelopathy/tropical spastic paraparesis) is a slowly progressive disease, characterized by a chronic spastic paraparesis. It is not known if the disease carries an independent risk for cardiovascular disease. The objective of this study was to evaluate the cardiovascular r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prado, Fabio Luís Silva do, Prado, Renata, Ladeia, Ana Marice Teixeira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427981/ https://www.ncbi.nlm.nih.gov/pubmed/28282508 http://dx.doi.org/10.1016/j.bjid.2017.01.007

Ejemplares similares

Diffusion tensor imaging metrics in diagnosis of HTLV‐1‐associated myelopathy
por: Liberato de Matos, Sheila N. F., et al.
Publicado: (2022)

HTLV-1-associated infective dermatitis and probable HTLV-1- associated myelopathy in an adolescent female
por: Steglich, Raquel Bisacotti, et al.
Publicado: (2015)

Prevalência das Complicações Cardiovasculares nos Indivíduos com Anemia Falciforme e Outras Hemoglobinopatias: Uma Revisão Sistemática
por: Lopes, Andressa, et al.
Publicado: (2022)

Treatment of patients with HTLV-1-associated myelopathy with methotrexate
por: Ahmed, S, et al.
Publicado: (2014)

Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy
por: von Glehn, Felipe, et al.
Publicado: (2012)

Susceptibility of Primary HTLV-1 Isolates from Patients with HTLV-1-Associated Myelopathy to Reverse Transcriptase Inhibitors
por: Macchi, Beatrice, et al.
Publicado: (2011)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

Absence of HTLV‐II Co‐infection in HTLV‐I‐associated Myelopathy Patients
por: Miyamoto, Kanji, et al.
Publicado: (1992)

Comparison of walking measures in patients with HTLV-1 Associated Myelopathy
por: Adonis, Adine, et al.
Publicado: (2015)

Amendment on brain signal intensity on Magnetic Resonance Imaging of asymptomatic HTLV-1 seropositive and HTLV-1 associated myelopathy
por: Bastos, Rafael HC, et al.
Publicado: (2014)

Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression
por: Souza, Flávia dos Santos, et al.
Publicado: (2021)

Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2014)

Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy
por: Buell, Kevin G., et al.
Publicado: (2016)

Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Schwalb, Alvaro, et al.
Publicado: (2020)

Balance assessment in HTLV-1 associated myelopathy or tropical spastic paraparesis
por: Patrício, Naiane Araújo, et al.
Publicado: (2020)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Burbelo, Peter D, et al.
Publicado: (2008)

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2017)

Chitotriosidase 1 in the cerebrospinal fluid as a putative biomarker for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) progression
por: Gomes, Yago Côrtes Pinheiro, et al.
Publicado: (2022)

INTERFERON BETA-1A TREATMENT IN HTLV-1-ASSOCIATED MYELOPATHY/TROPICAL SPASTIC PARAPARESIS: A CASE REPORT
por: Viana, Graça Maria de Castro, et al.
Publicado: (2014)

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kirk, Paul, et al.
Publicado: (2011)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kirk, Paul DW, et al.
Publicado: (2011)

A proof of concept study of Infliximab for the treatment of HTLV-1-associated myelopathy
por: Martin, Fabiola, et al.
Publicado: (2014)

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2016)

Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers
por: Harding, Daniel, et al.
Publicado: (2022)

Visualization of HTLV-1–Specific Cytotoxic T Lymphocytes in the Spinal Cords of Patients With HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis
por: Matsuura, Eiji, et al.
Publicado: (2015)

HTLV-1 proviral load in infective dermatitis associated with HTLV-1 does not increase after the development of HTLV-1-associated myelopathy/tropical spastic paraparesis and does not decrease after IDH remission
por: Batista, Everton S., et al.
Publicado: (2019)

Sensitivity and specificity of spinal cord Magnetic Resonance Imaging in the diagnosis of HTLV-1 associated myelopathy
por: Romanelli, Luiz CF, et al.
Publicado: (2014)

Editorial Commentary: Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) and HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis
por: Taylor, Graham P.
Publicado: (2015)

Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2020)

EZH1/2 dual inhibitors suppress HTLV-1-infected cell proliferation and hyperimmune response in HTLV-1-associated myelopathy
por: Koseki, Akihito, et al.
Publicado: (2023)

Proteomic profiling of HTLV-1 infected T-cells for the identification of potential biomarkers and therapeutic targets for HTLV-1 associated myelopathy/ tropical spastic paraparesis and adult T-cell leukemia
por: Ueda, Koji, et al.
Publicado: (2011)

Median Nerve Somatosensory Evoked Potential in HTLV-I Associated Myelopathy
por: Boostani, Reza, et al.
Publicado: (2016)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Rafatpanah, Houshang, et al.
Publicado: (2013)

Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Baratella, Marco, et al.
Publicado: (2017)

IL28B gene polymorphism SNP rs8099917 allele GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers
por: Assone dos Santos, Tatiane, et al.
Publicado: (2014)

BNZ-gamma peptide, a potential therapeutic agent in HTLV-1 associated myelopathy
por: Massoud, Raya, et al.
Publicado: (2014)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2019)

IL28B Gene Polymorphism SNP rs8099917 Genotype GG Is Associated with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in HTLV-1 Carriers
por: Assone, Tatiane, et al.
Publicado: (2014)

Human T-cell lymphotropic virus, type 1 (HTLV-1)-associated myelopathy: MR findings
por: Petscavage, Jonelle M., et al.
Publicado: (2015)

Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1–associated myelopathy/tropical spastic paraparesis
por: Nagasaka, Misako, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e1vfu9ip30ffkojh1pr52epr7o